Total Funding
90
77
Total FundingEquity Crowdfunding raised
Growth Score
-2 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
115106
Yomi Pharma is a biotech company that focuses on developing innovative therapeutic solutions for oncology.
About the Company
Yomi Pharma is a biotech company that focuses on developing innovative therapeutic solutions for oncology, specifically targeting lung adenocarcinoma resistant to current treatments. Their lead candidate, YomiPep, is a "first-in-class" patented anti-EGFR peptide that works at the gene transcription level to inhibit the EGFR receptor,
including rare mutations, offering a novel mechanism of action to overcome resistance to tyrosine kinase inhibitors.
